retatrutide dosing clinical trial Reta trial data & dosing — a must read Retatrutide (Reta) isn't just another GLP-1. It's a triple-agonist peptide Retatrutide Dosage: Personalized Dosing &

A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on

Market Drivers : Growth is driven by the rising prevalence of obesity and Type 2 diabetes, the shift toward incretin-based therapies, expanding clinical evidence of weight-loss benefits, and improved patient awareness, supported by physician advocacy and digital health engagement

Hwang and A

The ongoing shortage of GLP-1 medications is placing an immense strain on the millions of Americans who have obesity, are looking for help, and cannot access the care that they deserve

At Boca Medical Care, we are dedicated to providing innovative and comprehensive treatment options for our patients